A major barrier in synthetic biology has fallen. Scientists at the Max Planck Institute for Polymer Research, led by Director Katharina Landfester, have created a method to render artificial cell membranes porous. Until now, these lab-built structures remained virtually impermeable—a limitation that stifled their potential.
This breakthrough opens the door to applications in medical research and targeted drug delivery. By allowing chemical substances to pass through, the new membranes mimic the behavior of real cells more closely. The work was published in the journal ACS Nano.
The team's innovation addresses a fundamental constraint of artificial cells. Previous versions were sealed off from their environment, restricting their use in reactions requiring molecular exchange. Now, the porous channels enable controlled interactions—a prerequisite for drug release systems.
Further validation in biological settings is still needed. The researchers did not specify timelines for clinical translation, and scaling the method from lab to commercial use remains unaddressed in the release. The findings currently represent a proof of concept rather than an immediately deployable solution.
Even so, the advance marks a step forward for synthetic biology. As the field evolves, porous artificial cells could become a standard tool for drug delivery and biochemical synthesis.